{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:42:46Z","timestamp":1781685766423,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.dld.2003.09.003","type":"journal-article","created":{"date-parts":[[2003,11,27]],"date-time":"2003-11-27T12:13:27Z","timestamp":1069935207000},"page":"843-848","source":"Crossref","is-referenced-by-count":19,"title":["Unsolved problems in the management of patients with gastro-oesophageal reflux disease"],"prefix":"10.1016","volume":"35","author":[{"given":"V.","family":"Stanghellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cogliandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cogliandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"De Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Corinaldesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2003.09.003_BIB1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.276.12.983","article-title":"Gastro-oesophageal reflux disease","volume":"276","author":"Kahrilas","year":"1996","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.dld.2003.09.003_BIB2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/gut.44.2008.S1","article-title":"An evidence-based appraisal of reflux disease management\u2014the Genval Workshop Report","volume":"44","author":"Dent","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.dld.2003.09.003_BIB3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0140-6736(90)90287-F","article-title":"Symptoms of gastro-oesophageal reflux disease","volume":"335","author":"Klauser","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2003.09.003_BIB4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00042737-199802000-00004","article-title":"Gastro-esophageal reflux in primary care: an international study of different strategies with omeprazole","volume":"10","author":"Carlsson","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2003.09.003_BIB5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1026458604826","article-title":"Randomized trials with quality of life end points: are doctors\u2019 ratings of patients\u2019 physical symptoms interchangeable with patients\u2019 self-ratings?","volume":"6","author":"Stephens","year":"1997","journal-title":"Qual Life Res"},{"key":"10.1016\/j.dld.2003.09.003_BIB6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.324.7347.1193","article-title":"Patient non-compliance with paper diaries","volume":"324","author":"Stone","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2003.09.003_BIB7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/gut.45.2008.ii31","article-title":"Functional esophageal disorders","volume":"45","author":"Clouse","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.dld.2003.09.003_BIB8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/gut.50.suppl_4.iv17","article-title":"Definition of reflux disease and its separation from dyspepsia","volume":"50","author":"Dent","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.dld.2003.09.003_BIB9","first-page":"A472","article-title":"\u2018Start high\u2019\u2014a better acid suppression strategy for heartburn-dominant uninvestigated dyspepsia in primary care practice. The CADET-HR study","volume":"122","author":"Armstrong","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2003.09.003_BIB10","unstructured":"Castell DO. Introduction to pathophysiology of gastro-esophageal reflux disease. In: Castell DO, Wu WC, Ott DJ, editors. Gastro-esophageal reflux disease: pathogenesis, diagnosis, therapy. New York: Futura; 1985. p. 3\u20139."},{"key":"10.1016\/j.dld.2003.09.003_BIB11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1590-8658(01)80100-6","article-title":"Non-erosive reflux disease: the real problem in gastro-oesophageal reflux disease","volume":"33","author":"Quigley","year":"2001","journal-title":"Dig. Liver Dis"},{"key":"10.1016\/j.dld.2003.09.003_BIB12","first-page":"827","article-title":"Endoscopy-negative reflux disease","volume":"14","author":"Carlsson","year":"2000","journal-title":"Bailliere\u2019s Clin. Gastroenterol."},{"key":"10.1016\/j.dld.2003.09.003_BIB13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/gut.37.4.457","article-title":"Reflux-related symptoms in patients with normal esophageal exposure to acid","volume":"37","author":"Shi","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.dld.2003.09.003_BIB14","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.29.7.886","article-title":"Reproducibility of ambulatory esophageal pH monitoring","volume":"29","author":"Johnsson","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.dld.2003.09.003_BIB15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2036.1996.44186000.x","article-title":"Chapman RW","volume":"10","author":"Bate","year":"1996","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.003_BIB16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/00365529709011212","article-title":"Heartburn without oesophagitis. Efficacy of omeprazole therapy and features determining therapeutic response","volume":"32","author":"Lind","year":"1997","journal-title":"Scand. J Gastroenterol"},{"key":"10.1016\/j.dld.2003.09.003_BIB17","doi-asserted-by":"crossref","unstructured":"Van Pinxteren B, Numans M, Bonis P, Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-esophageal reflux disease-like symptoms and endoscopy negative reflux disease (Cochrane Review). In: The Cochrane library. Oxford: Update Software; 2002.","DOI":"10.1002\/14651858.CD002095"},{"key":"10.1016\/j.dld.2003.09.003_BIB18","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(87)92686-9","article-title":"The irritable esophagus\u2014a frequent cause of angina-like pain","volume":"1","author":"Vantrappen","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2003.09.003_BIB19","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/gast.1996.v111.pm8898633","article-title":"Dilated intercellular spaces: a morphological feature of acid reflux damaged human esophageal epithelium","volume":"111","author":"Tobey","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2003.09.003_BIB20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-1838(90)90149-D","article-title":"Mucosal peptidergic innervation of the opossum esophagus and anal canal: a comparison with snout skin","volume":"29","author":"Singaram","year":"1990","journal-title":"J Autonom Nerv Syst"},{"key":"10.1016\/j.dld.2003.09.003_BIB21","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1136\/gut.35.12.1690","article-title":"Nitrergic and peptidergic innervation of the human esophagus","volume":"35","author":"Singaram","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.dld.2003.09.003_BIB22","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0016-5085(91)90231-9","article-title":"Localization of calcitonin gene-related peptide in human esophageal Langerhans cells","volume":"100","author":"Singaram","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2003.09.003_BIB23","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0016-5085(99)70295-7","article-title":"Plasticity in the enteric nervous system","volume":"117","author":"Giaroni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2003.09.003_BIB24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/gut.51.suppl_1.i41","article-title":"A role for inflammation in irritable bowel syndrome?","volume":"51","author":"Barbara","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.dld.2003.09.003_BIB25","first-page":"22","article-title":"Primary upper aerodigestive tract manifestations of gastro-oesophageal reflux","volume":"83","author":"Pearlman","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2003.09.003_BIB26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000051392","article-title":"Prevalence of gastro-oesophageal reflux disease in patients with extraesophageal symptoms referred from otolaryngology, allergy, and cardiology practices: a prospective study","volume":"18","author":"Garcia-Compean","year":"2000","journal-title":"Dig Dis"},{"key":"10.1016\/j.dld.2003.09.003_BIB27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/000348949510400709","article-title":"Outcomes of antireflux therapy for the treatment of chronic laryngitis","volume":"104","author":"Hanson","year":"1995","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.dld.2003.09.003_BIB28","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/archinte.158.21.2373","article-title":"Heartburn requiring antacid use may indicate significant illness","volume":"158","author":"Robinson","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2003.09.003_BIB29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00004836-198812000-00007","article-title":"Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial","volume":"10","author":"Baldi","year":"1988","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.dld.2003.09.003_BIB30","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastro-oesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2003.09.003_BIB31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02090077","article-title":"Variability of individual response to various doses of omeprazole: implications for antiulcer therapy","volume":"39","author":"Savarino","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2003.09.003_BIB32","first-page":":29","article-title":"Shortcomings of the first generation proton pump inhibitors","volume":"13","author":"Tytgat","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2003.09.003_BIB33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1572-0241.2002.05532.x","article-title":"Esomeprazole 40 mg compared with lansoprazole 30 mg in the treatment of erosive esophagitis","volume":"97","author":"O\u2019Castell","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2003.09.003_BIB34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00044011-200222020-00004","article-title":"Evidence for therapeutic equivalence of lansoprazole 30 mg and esomeprazole 40 mg in the treatment of erosive esophagitis","volume":"22","author":"Howden","year":"2002","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.dld.2003.09.003_BIB35","first-page":":137","article-title":"Equivalent efficacy of pantoprazole 40 mg and esomeprazole 40 mg in patients with GORD","volume":"16","author":"Eissele","year":"2002","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2003.09.003_BIB36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1572-0241.1998.221_a.x","article-title":"Nocturnal recovery of gastric acid secretion with twice daily dosing proton pump inhibitors","volume":"93","author":"Peghini","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2003.09.003_BIB37","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1046\/j.1365-2036.2001.01050.x","article-title":"Bedtime H2 blockers improve nocturnal gastric acid control in GORD patients on proton pump inhibitors","volume":"15","author":"Xue","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2003.09.003_BIB38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000018685","article-title":"Possibilities and shortcomings of maintenance therapy in gastro-oesophageal reflux disease","volume":"16","author":"Tytgat","year":"1999","journal-title":"Dig Surg."},{"key":"10.1016\/j.dld.2003.09.003_BIB39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/bmj.318.7182.502","article-title":"Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group","volume":"318","author":"Bardhan","year":"1999","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2003.09.003_BIB40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1365-2036.1999.00564.x","article-title":"On demand therapy with omeprazole for the long-term management of patients with heartburn without esophagitis\u2014a placebo-controlled randomised trial","volume":"13","author":"Lind","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2003.09.003_BIB41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2036.2001.00943.x","article-title":"Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of \u2018on demand\u2019 therapy for 6 months","volume":"15","author":"Talley","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2003.09.003_BIB42","first-page":"485","article-title":"Gastro-oesophageal reflux disease pathophysiology","volume":"11","author":"Tougas","year":"2001","journal-title":"Chest Surg Clin North Am"},{"key":"10.1016\/j.dld.2003.09.003_BIB43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2036.2003.01394.x","article-title":"Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux mean by combined multichannel intraluminal impedance and pH","volume":"17","author":"Vela","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2003.09.003_BIB44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gut.52.4.464","article-title":"Effect of acute and chronic administration of the GABA B agonist baclofen on 24 h pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease","volume":"52","author":"Ciccaglione","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2003.09.003_BIB45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1091-255X(01)80012-3","article-title":"Five to eight year outcome of the first laparoscopic Nissen funduplications","volume":"16","author":"Bammer","year":"2001","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.dld.2003.09.003_BIB46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1072-7515(01)00992-9","article-title":"Complications and results of primary minimally invasive antireflux procedures: a review of 10,735 reported cases","volume":"193","author":"Carlson","year":"2001","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.dld.2003.09.003_BIB47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9343(02)01390-6","article-title":"Clinical effectiveness of laparoscopic funduplication in a U.S. community","volume":"114","author":"Vakil","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2003.09.003_BIB48","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1046\/j.1365-2036.2003.01601.x","article-title":"Review article: endoscopic treatments for gastro-oesophageal reflux disease","volume":"17","author":"Vakil","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2003.09.003_BIB49","unstructured":"Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/script\/cdrh\/cfdocs\/cfMAUDE\/search.cfm. Accessed 15 March 2003."},{"key":"10.1016\/j.dld.2003.09.003_BIB50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0889-8553(02)00044-4","article-title":"Surgical and endoscopic treatment of gastro-oesophageal reflux disease","volume":"31","author":"Waring","year":"2002","journal-title":"Gastroenterol Cin North Am"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865803005176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865803005176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T11:46:25Z","timestamp":1585309585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865803005176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1590865803005176"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2003.09.003","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}